FEAF
TWSE

1907 永豐餘

28.40 ▲ 0.35 (1.25%) Close · 2026-11-13 · TWSE
Ask about 1907
This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.

Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.

Your risk profile
Conclusion

Mixed picture: 1 strengths against 3 watch-outs. Weigh them against your own goals.

Points to watch for a moderate profile: see the items marked above.

No model narrative: the model call failed. The structured analysis above is complete on its own.

Strengths

+ The current price implies 1.1% perpetual growth, within the 3.5% ceiling: expectations look attainable. source (Valuation) →

Watch-outs

! Revenue fell -6.1% in 2025; latest quarter Q2 2026: 9.4% year on year. source (Financials) →
! Return on equity 3.1% with a 3.8% net margin: weak profitability. source (Key Stats) →
! Free cash flow was negative in 2025: -165 NT$ million, so spending exceeded operating cash. source (Financials) →

What to check before deciding

?Is the revenue decline temporary or structural?
?What would lift profitability, and how soon?
?What is the spending for, and when does it start paying back?

What the analysis found

+ Valuation (DCF) The current price implies 1.1% perpetual growth, within the 3.5% ceiling: expectations look attainable. source →
· Valuation vs peers P/E 16.71 is close to the Paper and pulp median of 17.52 (6 listed peers). source →
! Growth Revenue fell -6.1% in 2025; latest quarter Q2 2026: 9.4% year on year. source →
! Profitability Return on equity 3.1% with a 3.8% net margin: weak profitability. source →
· Debt Liabilities are 43.8% of total assets (Q2 2026). source →
! Cash flow Free cash flow was negative in 2025: -165 NT$ million, so spending exceeded operating cash. source →
· Filings 4 verified alert(s); latest on 2026-11-13: 永豐餘投資控股股份有限公司及其子公司公告背書保證事項 source →
· Filings 1 filing(s) are held or rejected and wait for human review. source →